NO985831D0 - Syntetiske polysakkarider, fremgangsmÕter for Õ fremstille dem og farmas°ytiske blandinger inneholdende nevnte polysakkarider - Google Patents

Syntetiske polysakkarider, fremgangsmÕter for Õ fremstille dem og farmas°ytiske blandinger inneholdende nevnte polysakkarider

Info

Publication number
NO985831D0
NO985831D0 NO985831A NO985831A NO985831D0 NO 985831 D0 NO985831 D0 NO 985831D0 NO 985831 A NO985831 A NO 985831A NO 985831 A NO985831 A NO 985831A NO 985831 D0 NO985831 D0 NO 985831D0
Authority
NO
Norway
Prior art keywords
polysaccharides
preparing
processes
pharmaceutical compositions
compositions containing
Prior art date
Application number
NO985831A
Other languages
English (en)
Other versions
NO985831L (no
NO319037B1 (no
Inventor
Philippe Duchaussoy
Jean-Marc Herbert
Guy Jauran
Marice Petitou
Constant Van Boeckel
Original Assignee
Sanofi Sa
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa, Akzo Nobel Nv filed Critical Sanofi Sa
Publication of NO985831D0 publication Critical patent/NO985831D0/no
Publication of NO985831L publication Critical patent/NO985831L/no
Publication of NO319037B1 publication Critical patent/NO319037B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Polymers & Plastics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Materials Engineering (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Oncology (AREA)
  • Transplantation (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Cephalosporin Compounds (AREA)
NO19985831A 1996-06-14 1998-12-11 Syntetiske polysakkarider, fremgangsmater for a fremstille dem og farmasoytiske blandinger inneholdende nevnte polysakkarider NO319037B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9607457A FR2749849B1 (fr) 1996-06-14 1996-06-14 Polysaccharides synthetiques, procede pour leur preparation et compositions pharmaceutiques les contenant
PCT/FR1997/001048 WO1997047659A1 (fr) 1996-06-14 1997-06-11 Polysaccharides synthetiques, procede pour leur preparation et compositions pharmaceutiques les contenant

Publications (3)

Publication Number Publication Date
NO985831D0 true NO985831D0 (no) 1998-12-11
NO985831L NO985831L (no) 1999-02-11
NO319037B1 NO319037B1 (no) 2005-06-06

Family

ID=9493087

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19985831A NO319037B1 (no) 1996-06-14 1998-12-11 Syntetiske polysakkarider, fremgangsmater for a fremstille dem og farmasoytiske blandinger inneholdende nevnte polysakkarider

Country Status (15)

Country Link
US (1) US7919614B2 (no)
EP (1) EP0904299B1 (no)
JP (1) JP3501813B2 (no)
AT (1) ATE204883T1 (no)
AU (1) AU3266797A (no)
BR (1) BR9709722B1 (no)
CA (1) CA2258146C (no)
CY (1) CY2281B1 (no)
DE (1) DE69706418T2 (no)
DK (1) DK0904299T3 (no)
ES (1) ES2163171T3 (no)
FR (1) FR2749849B1 (no)
NO (1) NO319037B1 (no)
PT (1) PT904299E (no)
WO (1) WO1997047659A1 (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2751334B1 (fr) * 1996-07-19 1998-10-16 Sanofi Sa Polysaccharides synthetiques, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2773804B1 (fr) * 1998-01-19 2000-02-18 Sanofi Sa Polysaccharides de synthese, procede pour leur preparation et compositions pharmaceutiques le contenant
EP1574516A1 (en) * 2004-03-05 2005-09-14 Sanofi-Aventis Antithrombotic compound
JP4796758B2 (ja) * 2004-08-24 2011-10-19 学校法人 京都産業大学 組成物及びそれを含有する抗腫瘍剤
TWI403334B (zh) 2004-12-23 2013-08-01 Merck Sharp & Dohme 包含生物素殘基之抗血栓雙重抑制劑
KR101529061B1 (ko) 2008-05-30 2015-06-16 모멘타 파머슈티컬스 인코포레이티드 당류 구조물, 그리고 이러한 구조물의 제조 및 사용 방법
FR2949114B1 (fr) 2009-08-14 2011-08-26 Sanofi Aventis OCTASACCHARIDES N-ACYLES ACTIVATEURS DES RECEPTEURS DES FGFs, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
FR2949115B1 (fr) * 2009-08-14 2012-11-02 Sanofi Aventis OLIGOSACCHARIDES N-SULFATES ACTIVATEURS DES RECEPTEURS DES FGFs, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
FR2970969B1 (fr) * 2011-01-27 2013-10-18 Sanofi Aventis Oligosaccharides 3-o-alkyles activateurs des recepteurs des fgfs, leur preparation et leur application en therapeutique
EP2578594A1 (en) * 2011-10-04 2013-04-10 Sanofi Process of preparation of L-iduronic acid comprising a decarboxylation/intramolecular cyclisation tandem reaction
WO2021211441A1 (en) * 2020-04-13 2021-10-21 The Board Of Regents Of The University Of Oklahoma Modified sugar polymers with low anticoagulant activity and therapeutic activity

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5529985A (en) * 1990-04-23 1996-06-25 Akzo Nobel Nv Sulfated glycosaminoglycanoid derivatives of the dermatan sulfate and chondroitin sulfate type
US5382570A (en) * 1990-04-23 1995-01-17 Akzo, N.V. Sulfated glycosaminoglycanoid derivatives of the dermatan sulfate and chondroitin sulfate type
US5378829A (en) * 1990-04-23 1995-01-03 Akzo N.V. Sulfated glycosaminoglycanoid derivatives of the heparin and heparan sulfate type
US5668274A (en) * 1991-04-23 1997-09-16 Akzo Nobel N.V. Sulfated glycosaminoglycanoid derivatives of the dermatan sulfate and chondroitin sulfate type

Also Published As

Publication number Publication date
BR9709722A (pt) 2000-01-25
DK0904299T3 (da) 2001-12-17
ES2163171T3 (es) 2002-01-16
NO985831L (no) 1999-02-11
FR2749849A1 (fr) 1997-12-19
AU3266797A (en) 1998-01-07
CY2281B1 (en) 2003-07-04
DE69706418T2 (de) 2002-05-29
JPH11513061A (ja) 1999-11-09
EP0904299B1 (fr) 2001-08-29
DE69706418D1 (de) 2001-10-04
NO319037B1 (no) 2005-06-06
EP0904299A1 (en) 1999-03-31
US7919614B2 (en) 2011-04-05
PT904299E (pt) 2002-02-28
US20040068108A1 (en) 2004-04-08
ATE204883T1 (de) 2001-09-15
JP3501813B2 (ja) 2004-03-02
BR9709722B1 (pt) 2010-12-14
WO1997047659A1 (fr) 1997-12-18
CA2258146C (fr) 2003-10-07
CA2258146A1 (fr) 1997-12-18
FR2749849B1 (fr) 1998-09-04

Similar Documents

Publication Publication Date Title
NO985831L (no) Syntetiske polysakkarider, fremgangsmÕter for Õ fremstille dem og farmas°ytiske blandinger inneholdende nevnte polysakkarider
NZ333721A (en) Pharmaceutically acceptable synthetic polysaccharides
HUP0204196A2 (hu) Antiangiogén aktivitással rendelkező és antikoaguláns hatástól mentes részlegesen deszulfatált glükózamininoglikán-származékok, eljárás előállításukra és ilyen vegyületeket tartalmazó gyógyászati készítmények
FR2617848B1 (fr) Polysaccharides extraits, notamment, de vegetaux utiles comme medicaments et additifs alimentaires
IT8723113A0 (it) Profilato da utilizzare con almeno due pannelli di soffitto o di parete.
ATE131176T1 (de) Sulfatierte polysaccharide, antikoagulierungs- und antikomplementärmittel, hergestellt aus fukanen aus braunen algen, und verfahren zu deren herstellung.
DE3485588D1 (de) Chondroitin-sulfat/natriumhyaluronat-zusammensetzungen.
BR8301521A (pt) Composicao viscosificante, processo de ativacao de hidroxietil celulose e fluido de manutencao de poco
PA8584201A1 (es) Mezcla de polisacaridos derivados de heparina, su preparacion y las composiciones farmaceuticas que las contienen
PT983304E (pt) Dissulfato de dermatano, um inibidor da producao de trombina e activacao do complemento
AR013904A1 (es) Oligomeros de poliesteres y de poli(estereteres) hidroxifunicionalizados, composiciones de materia, articulos y laminados que incluyen dichascomposiciones y procedimiento para preparar dichas composiciones
ES2147216T3 (es) Bisconjugados que comprenden dos sacaridos y un grupo de union.
ES2059381T3 (es) Particulas polimeras producidas secuencialmente, dispersiones acuosas de particulas polimeras producidas secuencialmente, procedimientos para la preparacion de particulas polimeras producidas secuencialmente y usos de particulas polimeras producidas secuencialmente.
DE69805757T2 (de) Polysaccharid, mikroorganismus und verfahren zu dessen herstellung, dieses enthaltende zusammensetzung und verwendung
ES2095894T3 (es) Derivados de galactomanano para el revestimiento o la incrustacion de productos activos farmaceuticos.
CA2023058A1 (en) Coating composition containing as thickeners polygalactomannans modified with hydrophilic and hydrophobic groups
GB1409149A (en) Quecetin derivatives and pharmaceutical uses thereof
DE2965524D1 (en) Rutin poly(h-) sulfates, method for their preparation and pharmaceutical compositions containing them
DE3780080D1 (de) Coccidiozide mittel.
ES8700268A1 (es) Un procedimiento para la preparacion de compuestos de eritromicina 6-0, 11-0, 6-11-di-0-alquilados.
DE69111119D1 (de) Durch Fermentation hergestellte Polysaccharide.
IT1267956B1 (it) Derivati o-solfatati di gangliosidi e lisogangliosidi
AS et al. < A> possible environmental effect in Kuwait of the Gulf War: changing conception rhythm
IT7824587A0 (it) Derivati taurinici ad attivita&#39;antilipemica e coleretica, processo per la loro preparazione e composizioni farmaceutiche che licontengono.
IT8621901A0 (it) Eparine, frazioni e frammenti eparinici esenti da edta, procedimenti per la loro preparazione e composizioni farmaceutiche che li contengono come principi attivi.

Legal Events

Date Code Title Description
MK1K Patent expired